Patents by Inventor M. Reddy

M. Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080015195
    Abstract: Novel FBPase inhibitors of the formula I and X are useful in the treatment of diabetes and other conditions associated with elevated blood glucose.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 17, 2008
    Applicant: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Srinivas Kasibhatla, K. Reddy, Mark Erion, M. Reddy, Atul Agarwal
  • Publication number: 20070243551
    Abstract: The present invention provides a useful system for assays that comprises a solid support, a plurality of capture oligonucleotides immobilized onto the solid support, and complementary oligonucleotides attached to capture ligands. A detectable label can be directly attached to the capture oligonucleotides or the complementary oligonucleotides. The labeled oligonucleotides can be detected, and used to determine the quality of the assay. A labeled detector ligand corresponding to a target ligand can also be independently detected apart from the labeled oligonucleotide.
    Type: Application
    Filed: May 9, 2007
    Publication date: October 18, 2007
    Applicant: Beckman Coulter, Inc.
    Inventors: M. Reddy, Daniel Keys, Firdous Farooqui
  • Publication number: 20070232571
    Abstract: Novel FBPase inhibitors of the formula I and X are useful in the treatment of diabetes and other conditions associated with elevated blood glucose.
    Type: Application
    Filed: April 30, 2007
    Publication date: October 4, 2007
    Applicant: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Srinivas Kasibhatla, K. Reddy, Mark Erion, M. Reddy, Atul Agarwal
  • Publication number: 20070009914
    Abstract: Methods for determining the presence of an analyte in a sample are disclosed, in which a capture agent is bound to the analyte at a first epitope and a detection agent is bound at a second epitope, and in which the detection agent includes an oligonucleotide to which a labeled, complementary oligonucleotide can be hybridized.
    Type: Application
    Filed: July 7, 2005
    Publication date: January 11, 2007
    Inventors: Robert Wallace, M. Reddy, Kurt Brillhart
  • Publication number: 20060292559
    Abstract: The present invention is in the field of chemistry and biotechnology. The present invention relates to cell-based microarrays, improved methods for forming such arrays, and methods for using such arrays in diagnostics, therapeutics and research. The invention particularly concerns microarrays in which ligands of a target cells are immobilized to the array support via ligand-binding molecules bound to an oligonucleotide that is hybridized to a support-immobilized oligonucleotide.
    Type: Application
    Filed: June 7, 2006
    Publication date: December 28, 2006
    Applicant: Beckman Coulter, Inc.
    Inventors: M. Reddy, Kurt Brillhart, Daniel Keys
  • Publication number: 20050277619
    Abstract: Novel purine compounds of Formula 1, pharmaceutically acceptable prodrugs and salts thereof, and their use as fructose 1,6-bisphosphatase inhibitors.
    Type: Application
    Filed: April 7, 2005
    Publication date: December 15, 2005
    Inventors: Qun Dang, Mark Erion, M. Reddy, Edward Robinson, Srinivas Kasibhatla, K. Reddy
  • Publication number: 20050059691
    Abstract: The present invention relates to a novel polymorphic form of 17-?-(N-ter.butyl carbamoyl)-4-aza-5-?-androst-1-en-3-one (Finasteride) of the formula (I) and processes for preparing the form.
    Type: Application
    Filed: March 15, 2004
    Publication date: March 17, 2005
    Inventors: M. Reddy, S. Rajan, M. Rao, K. Vyas, S. Reddy, K. Rekha